⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
globenewswire.com
MYGN
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight
globenewswire.com
CRSP
TMO
RGEN
ILMN
MYGN
DHR
QGEN
DGX
PACB
AMGN
AGNC
CELC
PERI
MRK
MTX
AZTA
ProgenyHealth Announces New Appointments to Company Leadership Board and Executive Team
prnewswire.com
MYGN
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
globenewswire.com
MYGN
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
globenewswire.com
MYGN
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
globenewswire.com
MYGN
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026
globenewswire.com
MYGN
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
globenewswire.com
MYGN
Myriad Genetics, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
MYGN
Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More
globenewswire.com
ILMN
QGEN
MDXH
MYGN